Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
12.31
-0.12 (-0.97%)
Sep 10, 2026, 12:44 PM CST
SHE:002275 Revenue
Guilin Sanjin Pharmaceutical had revenue of 443.48M CNY in the quarter ending June 30, 2026, a decrease of -16.60%. This brings the company's revenue in the last twelve months to 2.02B, down -5.08% year-over-year. In the year 2025, Guilin Sanjin Pharmaceutical had annual revenue of 2.05B, down -6.76%.
Revenue (ttm)
2.02B
Revenue Growth
-5.08%
P/S Ratio
3.62
Revenue / Employee
788.73K
Employees
2,556
Market Cap
7.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.05B | -148.26M | -6.76% |
| Dec 31, 2024 | 2.19B | 22.39M | 1.03% |
| Dec 31, 2023 | 2.17B | 211.87M | 10.81% |
| Jan 1, 2023 | 1.96B | 218.51M | 12.55% |
| Jan 1, 2022 | 1.74B | 174.74M | 11.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.58B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.73B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Zhejiang Tianyu Pharmaceutical | 3.50B |
| Jiangsu Kanion Pharmaceutical | 3.31B |
| Jiuzhitang | 2.60B |
| Hubei Hongyuan Pharmaceutical Technology | 2.40B |
| Guangxi Wuzhou Zhongheng Group | 1.24B |